Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies

Genes Chromosomes and Cancer

Volumn 45, Issue 6, 2006, Pages 583-591

  Chen, Yuyan ^a   Takita, Junko ^a   Hiwatari, Mitsuteru ^a   Igarashi, Takashi ^a   Hanada, Ryoji ^b   Kikuchi, Akira ^b   Hongo, Teruaki ^c   Taki, Tomohiko ^d   Ogasawara, Mizuho ^e   Shimada, Akira ^e   Hayashi, Yasuhide ^e  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e Gunma Children's Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CELL LINE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; GENE; GENE IDENTIFICATION; GENETIC RISK; GENETIC SCREENING; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; JUVENILE MYELOMONOCYTIC LEUKEMIA; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; ONCOGENE N RAS; ONCOGENE RAS; PATHOGENESIS; PRIORITY JOURNAL; PTPNII GENE; RHABDOMYOSARCOMA; RISK FACTOR; SOMATIC MUTATION;

CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOCYTIC, ACUTE; MUTATION; NEOPLASMS; PROTEIN-TYROSINE-PHOSPHATASE; RAS PROTEINS; RHABDOMYOSARCOMA;

EID: 33646589708     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1007/s11103-005-5082-x     Document Type: Article

References (49)

1. Agras PI, Baskin E, Sakallioglu AE, Arda IS, Ayter S, Oguzkan S, Derbent M, Alehan F, Hicsonmez A, Saatci U. 2003. Neurofibromatosis-Noonan's syndrome with associated rhabdomyosarcoma of the urinary bladder in an infant: case report. J Child Neurol 18:68-72.
2. Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, Filocamo M, Kato K, Suzuki Y, Kure S, Matsubara Y. 2005. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 37:1038-1040.
3. Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG. 2004. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res 64:8816-8820.
4. Bos JL. 1988. The ras gene family and human carcinogenesis. Mutat Res 195:255-271.
5. Brodeur GM. 2003. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203-216.
6. Chardin P, Yeramian P, Madaule P, Tavitian A. 1985. N-ras gene activation in the RD human rhabdomyosarcoma cell line. Int J Cancer 35:647-652.
7. Chen YY, Takita J, Tanaka K, Ida K, Koh K, Igarashi T, Hanada R, Kikuchi A, Tanaka Y, Toyoda Y, Hayashi Y. 2005. Aberrations of the CHK2 gene are rare in pediatric solid tumors. Int J Mol Med 16:85-91.
8. Cotton JL, Williams RG. 1995. Noonan syndrome and neuroblastoma. Arch Pediatr Adolesc Med 149:1280-1281.
9. Fragale A, Tartaglia M, Wu J, Gelb BD. 2004. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. Hum Mutat 23:267-277.
10. Gurney JG, Ross JA, Wall DA, Bleyer WA, Severson RK, Robison LL. 1997. Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol 19:428-32.
11. Hayashi K. 1991. PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl 1:34-38.
12. Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92:441-450.
13. Ijiri R, Tanaka Y, Kato K, Masuno M, Imaizumi K. 2000. A case of Noonan's syndrome with possible associated neuroblastoma. Pediatr Radiol 30:432-433.
14. Ireland CM. 1989. Activated N-ras oncogenes in human neuroblastoma. Cancer Res 49:5530-5533.
15. Jung A, Bechthold S, Pfluger T, Renner C, Ehrt O. 2003. Orbital rhabdomyosarcoma in Noonan syndrome. J Pediatr Hematol Oncol 25:330-332.
16. Kawamura M, Kikuchi A, Kobayashi S, Hanada R, Yamamoto K, Horibe K, Shikano T, Ueda K, Hayashi K, Sekiya T, Hayashi Y. 1995. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia. Blood 85:2546-2552.
17. Kawamura M, Ohnishi H, Guo SX, Sheng XM, Minegishi M, Hanada R, Horibe K, Hongo T, Kaneko Y, Bessho F, Yanagisawa M, Sekiya T, Hayashi Y. 1999. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Leuk Res 23:115-126.
18. Keilhack H, David FS, McGregor M, Cantley LC, Neel BG. 2005. Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. J Biol Chem 280:30984-30993.
19. Khan S, McDowell H, Upadhyaya M, Fryer A. 1995. Vaginal rhabdomyosarcoma in a patient with Noonan syndrome. J Med Genet 32:743-745.
20. Kratz CP, Niemeyer CM, Castleberry RP, Cetin M, Bergstrasser E, Emanuel PD, Hasle H, Kardos G, Klein C, Kojima S, Stary J, Trebo M, Zecca M, Gelb BD, Tartaglia M, Loh ML. 2005. The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood 106:2183-2185.
21. Loh ML, Reynolds MG, Vattikuti S, Gerbing RB, Alonzo TA, Carlson E, Cheng JW, Lee CM, Lange BJ, Meshinchi S. 2004a. PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group. Leukemia 18:1831-1834.
22. Loh ML, Vattikuti S, Schubbert S, Reynolds MG, Carlson E, Lieuw KH, Cheng JW, Lee CM, Stokoe D, Bonifas JM, Curtiss NP, Gotlib J, Meshinchi S, Le Beau MM, Emanuel PD, Shannon KM. 2004b. Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103:2325-2331.
23. Lopez-Miranda B, Westra SJ, Yazdani S, Boechat MI. 1997. Noonan syndrome associated with neuroblastoma: a case report. Pediatr Radiol 27:324-326.
24. Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S. 1994. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 83:2248-2254.
25. Mohi MG, Williams IR, Dearolf CR, Chan G, Kutok JL, Cohen S, Morgan K, Boulton C, Shigematsu H, Keilhack H, Akashi K, Gilliland DG, Neel BG. 2005. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 7:179-191.
26. Neel BG, Gu H, Pao L. 2003. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28:284-293.
27. Niihori T, Aoki Y, Ohashi H, Kurosawa K, Kondoh T, Ishikiriyama S, Kawame H, Kamasaki H, Yamanaka T, Takada F, Nishio K, Sakurai M, Tamai H, Nagashima T, Suzuki Y, Kure S, Fujii K, Imaizumi M, Matsubara Y. 2005. Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia. J Hum Genet 50:192-202.
28. O'Reilly AM, Pluskey S, Shoelson SE, Neel BG. 2000. Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps. Mol Cell Biol 20:299-311.
29. Qu CK, Nguyen S, Chen J, Feng GS. 2001. Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood 97:911-914.
30. Qu CK, Yu WM, Azzarelli B, Cooper S, Broxmeyer HE, Feng GS. 1998. Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells. Mol Cell Biol 18:6075-6082.
31. Saxton TM, Ciruna BG, Holmyard D, Kulkarni S, Harpal K, Rossant J, Pawson T. 2000. The SH2 tyrosine phosphatase shp2 is required for mammalian limb development. Nat Genet 24:420-423.
32. Schubbert S, Lieuw K, Rowe SL, Lee CM, Li X, Loh ML, Clapp DW, Shannon KM. 2005. Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood 106:311-317.
33. Sheng XM, Kawamura M, Ohnishi H, Ida K, Hanada R, Kojima S, Kobayashi M, Bessho F, Yanagisawa M, Hayashi Y. 1997. Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia. Leuk Res 21:697-701.
34. Shibuya N, Taki T, Mugishima H, Chin M, Tsuchida M, Sako M, Kawa K, Ishii E, Miura I, Yanagisawa M, Hayashi Y. 2001. t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines. Genes Chromosomes Cancer 32:1-10.
35. Side LE, Emanuel PD, Taylor B, Franklin J, Thompson P, Castleberry RP, Shannon KM. 1998. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 92:267-272.
36. Stratton MR, Fisher C, Gusterson BA, Cooper CS. 1989. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res 49:6324-6327.
37. Taketani T, Taki T, Ono R, Kobayashi Y, Ida K, Hayashi Y. 2002. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9. Genes Chromosomes Cancer 34:437-443.
38. Taketani T, Taki T, Sugita K, Furuichi Y, Ishii E, Hanada R, Tsuchida M, Ida K, Hayashi Y. 2004. FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy. Blood 103:1085-1088.
39. Takita J, Ishii M, Tsutsumi S, Tanaka Y, Kato K, Toyoda Y, Hanada R, Yamamoto K, Hayashi Y, Aburatani H. 2004. Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma. Genes Chromosomes Cancer 40:120-132.
40. Takita J, Yang HW, Chen YY, Hanada R, Yamamoto K, Teitz T, Kidd V, Hayashi Y. 2001. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene 20:4424-4432.
41. Tartaglia M, Cordeddu V, Chang H, Shaw A, Kalidas K, Crosby A, Patton MA, Sorcini M, van der Burgt I, Jeffery S, Gelb BD. 2004a. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. Am J Hum Genet 75:492-497.
42. Tartaglia M, Gelb BD. 2005. Germ-line and somatic PTPN11 mutations in human disease. Eur J Med Genet 48:81-96.
43. Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD. 2002. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70:1555-1563.
44. Tartaglia M, Martinelli S, Cazzaniga G, Cordeddu V, Iavarone I, Spinelli M, Palmi C, Carta C, Pession A, Arico M, Masera G, Basso G, Sorcini M, Gelb BD, Biondi A. 2004b. Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood 104:307-313.
45. Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, Zampino G, Burgt IV, Palleschi A, Petrucci TC, Sorcini M, Schoch C, Foa R, Emanuel PD, Gelb BD. 2006. Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human Disease. Am J Hum Genet 78:279-290.
46. Tartaglia M, Mehler EL, Goldberg R, Zampiho G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. 2001. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465-468.
47. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hahlen K, Hasle H, Licht JD, Gelb BD. 2003. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148-150.
48. Uno K, Takita J, Yokomori K, Tanaka Y, Ohta S, Shimada H, Gilles FH, Sugita K, Abe S, Sako M and others. 2002. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Genes Chromosomes Cancer 34:33-41.
49. Yang HW, Chen YZ, Takita J, Soeda E, Piao HY, Hayashi Y. 2001. Genomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2. Oncogene 20:5075-5083.